loadpatents
name:-0.53789401054382
name:-0.039278984069824
name:-0.015985012054443
Shah; Mandar V. Patent Filings

Shah; Mandar V.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shah; Mandar V..The latest application filed is for "moxifloxacin and triamcinolone compositions and associated methods".

Company Profile
11.23.56
  • Shah; Mandar V. - Rockaway NJ
  • Shah; Mandar V. - Somerset NJ
  • Shah; Mandar V - Rockaway NJ
  • Shah; Mandar V. - New Delhi IN
  • Shah; Mandar V - Somerset NJ
  • SHAH; Mandar V. - Haryana IN
  • Shah; Mandar V. - Arlington TX
  • Shah, Mandar V - Arlington TX
  • Shah; Mandar V. - Forth Worth TX
  • Shah; Mandar V. - Fort Worth TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Suspension component-specific triamcinolone and moxifloxacin compositions and associated methods of use
Grant 11,446,242 - Shah , et al. September 20, 2
2022-09-20
Moxifloxacin and triamcinolone compositions and associated methods
Grant 11,439,591 - Shah , et al. September 13, 2
2022-09-13
Glycopeptide antibiotics liquid formulations and methods and uses thereof
Grant 11,433,115 - Shah , et al. September 6, 2
2022-09-06
Liquid ready-to-use formulation of levothyroxine
Grant 11,400,068 - Akasapu , et al. August 2, 2
2022-08-02
Effective benzalkonium chloride-free bimatoprost ophthalmic compositions
Grant 11,400,100 - Shah , et al. August 2, 2
2022-08-02
Combination products of tobramycin compounds and dexameihasone compounds
Grant 11,395,831 - Shah , et al. July 26, 2
2022-07-26
Loteprednol and moxifloxacin compositions and methods
Grant 11,382,910 - Shah , et al. July 12, 2
2022-07-12
Moxifloxacin And Triamcinolone Compositions And Associated Methods
App 20220183966 - Shah; Mandar V. ;   et al.
2022-06-16
Suspension Component-specific Triamcinolone And Moxifloxacin Compositions And Associated Methods Of Use
App 20220183968 - Shah; Mandar V. ;   et al.
2022-06-16
Limited Particle Size Triamcinolone And Moxifloxacin Compositions And Associated Methods Of Use
App 20220183967 - Shah; Mandar V. ;   et al.
2022-06-16
Tobramycin compound conjugates and derivative compositions
Grant 11,344,566 - Shah , et al. May 31, 2
2022-05-31
Glycopeptide Antibiotics Liquid Formulations And Methods And Uses Thereof
App 20220133844 - SHAH; Mandar V. ;   et al.
2022-05-05
Glycopeptide Antibiotics Liquid Formulations And Methods And Uses Thereof
App 20220133845 - SHAH; Mandar V. ;   et al.
2022-05-05
Efficient tobramycin compound conjugate compositions
Grant 11,298,368 - Shah , et al. April 12, 2
2022-04-12
Triamcinolone and moxifloxacin compositions
Grant 11,298,315 - Shah , et al. April 12, 2
2022-04-12
Safe Use Of Brinzolamide And Brimonidine Compositions With Enhanced Benzalkonium Chloride Content
App 20220105103 - Shah; Mandar V. ;   et al.
2022-04-07
Methods Of Efficiently Reducing Intraocular Pressure
App 20220105102 - Shah; Mandar V. ;   et al.
2022-04-07
Safe Brinzolamide And Brimonidine Compositions With Enhanced Benzalkonium Chloride Content
App 20220105100 - Shah; Mandar V. ;   et al.
2022-04-07
Efficient Brinzolamide And Brimonidine Compositions
App 20220105101 - Shah; Mandar V. ;   et al.
2022-04-07
Ophthalmic solution
Grant 11,285,163 - Shah , et al. March 29, 2
2022-03-29
Triamcinolone And Moxifloxacin Compositions
App 20220062167 - Shah; Mandar V. ;   et al.
2022-03-03
Loteprednol And Moxifloxacin Compositions And Methods
App 20220062271 - Shah; Mandar V. ;   et al.
2022-03-03
Gatifloxacin, Prednisolone, And Bromfenac Compositions And Methods
App 20220062302 - Shah; Mandar V. ;   et al.
2022-03-03
Trimcinolone And Moxifloxacin Methods
App 20220062168 - Shah; Mandar V. ;   et al.
2022-03-03
Bromfenac, Prednisolone, And Moxifloxacin Compositions And Methods
App 20220062301 - Shah; Mandar V. ;   et al.
2022-03-03
Prednisolone And Moxifloxacin Compositions And Methods
App 20220062303 - Shah; Mandar V. ;   et al.
2022-03-03
Tobramycin Compound-copolymer Conjugates And Derivative Compositions
App 20220054517 - Shah; Mandar V. ;   et al.
2022-02-24
Tobramycin Compound Conjugate Formulations
App 20220054518 - Shah; Mandar V. ;   et al.
2022-02-24
Efficient Tobramycin Compound Conjugate Compositions
App 20220054519 - Shah; Mandar V. ;   et al.
2022-02-24
Epinephrine Parenteral Formulations
App 20220016054 - Shah; Mandar V. ;   et al.
2022-01-20
Liquid Ready-to-use Formulation Of Levothyroxine
App 20210386699 - Akasapu; Prem Sagar ;   et al.
2021-12-16
Tobramycin Compound Conjugates And Derivative Compositions
App 20210361685 - Shah; Mandar V. ;   et al.
2021-11-25
Combination Products Of Tobramycin Compounds And Dexamethasone Compounds
App 20210361687 - Shah; Mandar V. ;   et al.
2021-11-25
Methods Of Treating Eye Disease With Tobramycin-related Compositions
App 20210361686 - Shah; Mandar V. ;   et al.
2021-11-25
Cetirizine Ophthalmic Compositions
App 20210299121 - Shah; Mandar V. ;   et al.
2021-09-30
Low Benzalkonium Chloride Bimatoprost Ophthalmic Compositions With Effective Penetration & Preservation Properties
App 20210205327 - Shah; Mandar V. ;   et al.
2021-07-08
Low Benzalkonium Chloride Bimatoprost Ophthalmic Compositions With Effective Penetration & Preservation Properties
App 20210177863 - Shah; Mandar V. ;   et al.
2021-06-17
Effective Benzalkonium Chloride-free Bimatoprost Ophthalmic Compositions
App 20210177780 - Shah; Mandar V ;   et al.
2021-06-17
Pharmaceutical Composition Comprising Brinzolamide
App 20200197522 - SHAH; Mandar V. ;   et al.
2020-06-25
Topical Brimonidine Tartrate Ophthalmic Solution
App 20200129505 - Shah; Mandar V. ;   et al.
2020-04-30
Pharmaceutical composition comprising brinzolamide
Grant 10,632,198 - Shah , et al.
2020-04-28
Topical brimonidine tartrate ophthalmic solution
Grant 10,517,869 - Shah , et al. Dec
2019-12-31
Process for manufacturing sterile ophthalmic pharmaceutical suspensions
Grant 10,463,674 - Shah , et al. No
2019-11-05
Preservative-free ophthalmic pharmaceutical formulation
Grant 9,801,813 - Shah , et al. October 31, 2
2017-10-31
Ophthalmic Solution
App 20170304316 - Shah; Mandar V. ;   et al.
2017-10-26
Stable Bromfenac Ophthalmic Solution
App 20170000889 - Shah; Mandar V. ;   et al.
2017-01-05
Pharmaceutical Composition Comprising Brinzolamide
App 20160339105 - SHAH; Mandar V. ;   et al.
2016-11-24
Topical Brimonidine Tartrate Ophthalmic Solution
App 20160331745 - Shah; Mandar V. ;   et al.
2016-11-17
An Improved Process For Manufacturing Sterile Ophthalmic Pharmaceutical Suspensions
App 20160279139 - Shah; Mandar V. ;   et al.
2016-09-29
Preservative-free Ophthalmic Pharmaceutical Formulation
App 20160235665 - SHAH; Mandar V. ;   et al.
2016-08-18
Stable Bromfenac Solution
App 20160143869 - SHAH; Mandar V. ;   et al.
2016-05-26
Sterile Ophthalmic Pharmaceutical Suspensions
App 20150297609 - Shah; Mandar V. ;   et al.
2015-10-22
Antispasmodic 1,2-diols And 1,2,3-triols
App 20140364401 - Shah; Priti Sanghvi ;   et al.
2014-12-11
Antispasmodic 1,2-Diols and 1,2,3-triols
Grant 8,853,189 - Shah , et al. October 7, 2
2014-10-07
Soothing Agents
App 20120213717 - Shah; Mandar V.
2012-08-23
Self-Preserving Compositions
App 20100227003 - Shah; Mandar V. ;   et al.
2010-09-09
Intraocular Irrigating Solutions And Methods For Treating Corneal Edema
App 20090264375 - SHAH; Mandar V. ;   et al.
2009-10-22
Intraocular Irrigating Solution Having Improved Flow Characteristics
App 20090258955 - Shah; Mandar V. ;   et al.
2009-10-15
Stabilized Glycerophosphate-containing Surgical Irrigating Solution
App 20090239957 - SHAH; Mandar V. ;   et al.
2009-09-24
Surface modified viscoelastics for ocular surgery
Grant 7,578,809 - Shah August 25, 2
2009-08-25
Dilution resistant viscoelastic compositions
Grant 7,363,928 - Shah April 29, 2
2008-04-29
Intraocular Irrigating Solution Having Improved Flow Characteristics
App 20080020017 - Shah; Mandar V. ;   et al.
2008-01-24
Self-preserving composition
App 20070297990 - Shah; Mandar V. ;   et al.
2007-12-27
Solution For Removing Cataracts Via Liquefracture
App 20070173448 - Shah; Mandar V. ;   et al.
2007-07-26
Solution for removing cataracts via liquefracture
Grant 7,169,755 - Shah , et al. January 30, 2
2007-01-30
Intraocular irrigating solution having improved flow characteristics
Grant 7,084,130 - Shah , et al. August 1, 2
2006-08-01
Surface modified viscoelastics for ocular surgery
App 20060090766 - Shah; Mandar V.
2006-05-04
Dilution resistant viscoelastic compositions
App 20060003964 - Shah; Mandar V. ;   et al.
2006-01-05
Intraocular irrigating solution having improved flow characteristics
App 20050148542 - Shah, Mandar V. ;   et al.
2005-07-07
Dilution resistant viscoelastic compositions
App 20040241155 - Shah, Mandar V.
2004-12-02
Surface modified viscoelastics for ocular surgery
App 20040118414 - Shah, Mandar V
2004-06-24
Solution for removing cataracts via liquefracture
App 20040053818 - Shah, Mandar V. ;   et al.
2004-03-18
Stable surgical irrigating solutions
App 20030138499 - Shah, Mandar V. ;   et al.
2003-07-24
Intraocular irrigating solution having improved flow characteristics
App 20030109424 - Shah, Mandar V. ;   et al.
2003-06-12
Ophthalmic compositions containing galactomannan polymers and borate
Grant 6,486,138 - Asgharian , et al. November 26, 2
2002-11-26
Gelling ophthalmic compositions containing xanthan gum
Grant 6,261,547 - Bawa , et al. July 17, 2
2001-07-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed